Table 2 Successive steps involved for the calibration and application of the prototype “IgHκ calibrator beads”.

From: Prototyping Trastuzumab Docetaxel Immunoliposomes with a New FCM-Based Method to Quantify Optimal Antibody Density on Nanoparticles

Calibrator beads

QIFIkit (commercial)

Midi-QIFIkit (prototype)

Mini-QIFIkit (prototype)

µ-QIFIkit (prototype)

“IgHκ beads” (protoype)

“IgHκ beads” (prototype)

Diameter

10 µm

3 µm

3 µm

1 µm

1 µm

1 µm

Coated analyte

Mouse IgG1

Biotin-IgG1 (mouse)

Biotin-IgG1 (mouse)

Biotin-IgG1 (mouse)

REAfinity* CD151-biotin (human IgG-k)

Trastuzumab on liposomes (human IgG-k)

Coating method

Proprietary

Magnetic SA-beads

Magnetic SA-beads

Magnetic SA-beads

Magnetic SA-beads

Covalent coupling

Calibration FCM instrument

FC500 and/or Gallios

Gallios

CytoFLEX-S

CytoFLEX-S

CytoFLEX-S

CytoFLEX-S

Staining method

QIFI (indirect IF with unlabeled mouse IgGs)

QIFI (indirect IF with unlabeled mouse IgGs)

QIFI (indirect IF with unlabeled mouse IgGs)

QIFI (indirect IF with unlabeled mouse IgGs)

QIFI (indirect IF with unlabeled mouse IgGs)

Direct IF with L1C1-PE (anti-human kappa)

Laser height at interrogation point

= or >10 µm, (depending on instrument)

10 µm

5 µm

5 µm

5 µm

5 µm

Excitation λ

488 nm

488 nm

561 nm

561 nm

561 nm

561 nm

Calibration channel

FITC

FITC

PE

PE

PE

PE

Calibration curve(s)

N.A.

Fig. S1a

Fig. S1b

Fig. S1c

Fig. 1

Fig. 2